Insider Trading March 9, 2026

Slide Insurance CEO Executes $9.99M Stock Sale Under 10b5-1 Plan

Bruce Lucas disposed of 532,437 shares across three trades in early March while retaining significant indirect and direct holdings

By Avery Klein SLDE
Slide Insurance CEO Executes $9.99M Stock Sale Under 10b5-1 Plan
SLDE

Slide Insurance Holdings (NASDAQ: SLDE) Chief Executive Officer Bruce Lucas sold 532,437 shares of common stock between March 5 and March 9, 2026, generating proceeds of $9.99 million under a pre-arranged 10b5-1 trading plan adopted on November 21, 2025. The transactions were completed in three tranches at average prices ranging from $18.23 to $19.37. Lucas retains substantial ownership stakes through multiple vehicles and trusts. Separately, the company delivered a stronger-than-expected fourth-quarter 2025, with earnings and revenue beats that prompted Keefe, Bruyette & Woods to raise its price target to $23.

Key Points

  • CEO Bruce Lucas sold 532,437 shares of Slide Insurance (SLDE) between March 5 and March 9, 2026, for total proceeds of $9.99 million under a 10b5-1 plan adopted on November 21, 2025 - sectors impacted: Insurance, Public Equities.
  • The dispositions were completed in three trades at average prices of $19.37, $18.59 and $18.23; the stock trades at $17.70 and remains below its 52-week high of $25.90 - sectors impacted: Capital markets, Financial services.
  • Lucas continues to hold large positions through multiple vehicles and trusts, including 39,342,563 shares indirectly via IIM Holdings II, LLC and 1,123,646 shares directly.

Transaction overview

Slide Insurance Holdings (NASDAQ: SLDE) Chief Executive Officer Bruce Lucas reported the sale of 532,437 shares of common stock in a Form 4 filing with the Securities and Exchange Commission. The disposition occurred over three separate transactions between March 5 and March 9, 2026, producing total proceeds of $9.99 million. The shares were sold at prices ranging from $18.23 to $19.37 per share.

Breakdown of the sales

The filing details the three trades:

  • March 5 - 172,644 shares sold at an average price of $19.37;
  • March 6 - 241,493 shares sold at an average price of $18.59;
  • March 9 - 118,300 shares sold at an average price of $18.23.

These transactions were executed pursuant to a pre-arranged 10b5-1 trading plan that Lucas adopted on November 21, 2025, according to the filing.

Ownership following the sales

Even after these dispositions, Lucas maintains a substantial position in Slide Insurance through a combination of direct and indirect holdings. The filing states he indirectly owns 39,342,563 shares via IIM Holdings II, LLC. In addition, Lucas directly holds 1,123,646 shares. Other holdings attributed to him include 2,575,837 shares indirectly owned through the Bruce Lucas Irrevocable Grantor Retained Annuity Trust of 2014; 194,201 shares beneficially owned by his spouse; 1,597,341 shares beneficially owned by his spouse through Securus Risk Management LLC; and two separate 1,925,000-share stakes held through the Emma Cloonen Irrevocable Trust and the Ava Cloonen Irrevocable Trust, respectively.

The filing notes that the shares sold were indirectly owned through IIM Holdings II, LLC, an entity controlled by Lucas, and that he disclaims beneficial ownership of those securities except to the extent of his pecuniary interest.

Market context

At the time of reporting, Slide Insurance shares trade at $17.70, below the company’s 52-week high of $25.90 but up more than 31% over the past six months. The recent sales were completed at prices modestly above the current trading level but below the 52-week peak.

Recent financial results and analyst action

Slide Insurance reported a strong fourth quarter for 2025, with adjusted earnings per share of $1.23 versus an analyst consensus forecast of $0.71, representing a reported earnings surprise of 73.24%. Revenue for the quarter was $347 million, rising from $238.5 million in the year-ago period.

Following the quarterly results, Keefe, Bruyette & Woods increased its price target on Slide Insurance to $23 from $22 and maintained an Outperform rating. The firm cited the company’s potent fourth-quarter performance and higher accretion from the referenced Citizens takeout activity as the rationale for its adjustment.

Valuation signal reported

Analysis from InvestingPro included in the filing commentary indicates the stock appears undervalued at current levels and assigns the company an "EXCELLENT" Financial Health Score of 3.89. The commentary also notes that InvestingPro provides Fair Value estimates and Pro Research Reports covering SLDE and more than 1,400 other U.S. equities.

What the filing shows - and what it does not

The Form 4 documents the mechanics and timing of Lucas’ trades and clarifies his post-transaction holdings across multiple entities and trusts. The filing also specifies that the sales were executed under a 10b5-1 plan adopted on November 21, 2025. The filing does not provide additional commentary from Lucas or Slide Insurance about the rationale beyond the plan structure, nor does it report any changes to executive roles or to the company’s capital allocation policy.


Note: This item reports the transaction details disclosed in the SEC filing and summarizes related public financial disclosures and analyst commentary cited alongside the filing.

Risks

  • Share-price volatility - SLDE is trading materially below its 52-week high, which may reflect market sensitivity to earnings, M&A-related accretion expectations or insider activity - sectors impacted: Equity markets, Insurance.
  • Complex ownership structure - Significant holdings are spread across multiple entities and trusts, and Lucas disclaims beneficial ownership of some shares except for his pecuniary interest; this may complicate assessments of insider intentions - sectors impacted: Corporate governance, Financial services.
  • Reliance on transaction disclosures - The Form 4 confirms the mechanics and timing of sales but provides limited information about intent beyond execution under a 10b5-1 plan; conclusions about strategic implications are therefore constrained - sectors impacted: Regulatory reporting, Investor relations.

More from Insider Trading

Procept BioRobotics director makes $10.48m run of stock purchases as company faces mixed analyst reactions Mar 10, 2026 Q2 Holdings CPO Disposes $1.3M in Stock Amid Recent Price Weakness Mar 10, 2026 Cactus Inc. Chairman Disposes $3.2M in Stock Amid Solid Q4 Results Mar 10, 2026 Arthur J. Gallagher VP Disposes of $908K in Stock; Exercises Options Same Day Mar 10, 2026 Ouster Director Virginia Boulet Adds $136,175 in Stock via Multiple Purchases Mar 10, 2026